Combined use of 0.1% fluorometholone and meibomian gland expression improves symptoms of moderate and severe dry eye disease, even in patients with systemic immune disease

References

• Lu P, Chen X, Liu X, et al. Dry eye syndrome in elderly Tibetans at high altitude: a population-based study in China. Cornea. 2008;27:545–551.
   PubMed Web of Science ®Google Scholar
• Jie Y, Xu L, Wu YY, et al. Prevalence of dry eye among adult Chinese in the Beijing Eye Study. Eye. 2009;23:688–693.
   PubMed Web of Science ®Google Scholar
• Tian YJ, Liu Y, Zou HD, et al. [Epidemiologic study of dry eye in populations equal or over 20 years old in Jiangning District of Shanghai]. [Zhonghua yan ke za zhi] Chin J Ophthalmol. 2009;45:486–491.
   Google Scholar
• Guo B, Lu P, Chen X, et al. Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Ophthalmic Epidemiol. 2010;17:234–241.
   PubMed Web of Science ®Google Scholar
• Han SB, Hyon JY, Woo SJ, et al. Prevalence of dry eye disease in an elderly Korean population. Arch Ophthalmol. 2011;129:633–638.
   PubMedGoogle Scholar
• Uchino M, Dogru M, Yagi Y, et al. The features of dry eye disease in a Japanese elderly population. Optom Vis Sci. 2006;83:797–802.
   PubMed Web of Science ®Google Scholar
• Siak JJ, Tong L, Wong WL, et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea. 2012;31:1223–1228.
   PubMed Web of Science ®Google Scholar
• Lemp MA. Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes. CLAO J. 1995;21:221–232.
   PubMedGoogle Scholar
• Kunert KS, Tisdale AS, Stern ME, et al. Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes. Arch Ophthalmol. 2000;118:1489–1496.
   PubMed Web of Science ®Google Scholar
• Siebelmann S, Gehlsen U, Huttmann G, et al. Development, alteration and real time dynamics of conjunctiva-associated lymphoid tissue. PLoS One. 2013;8:e82355.
   PubMed Web of Science ®Google Scholar
• Niederkorn JY, Stern ME, Pflugfelder SC, et al. Desiccating stress induces T cell-mediated Sjogren's syndrome-like lacrimal keratoconjunctivitis. J Immunol. 2006;176:3950–3957.
   PubMed Web of Science ®Google Scholar
• Stern ME, Gao J, Schwalb TA, et al. Conjunctival T-cell subpopulations in Sjogren's and non-Sjogren's patients with dry eye. Investig Ophthalmol Vis Sci. 2002;43:2609–2614.
   PubMed Web of Science ®Google Scholar
• Avunduk AM, Avunduk MC, Varnell ED, et al. The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study. Am J Ophthalmol. 2003;136:593–602.
   PubMed Web of Science ®Google Scholar
• Lee HK, Ryu IH, Seo KY, et al. Topical 0.1% prednisolone lowers nerve growth factor expression in keratoconjunctivitis sicca patients. Ophthalmology. 2006;113:198–205.
   PubMed Web of Science ®Google Scholar
• Aragona P, Spinella R, Rania L, et al. Safety and efficacy of 0.1% clobetasone butyrate eyedrops in the treatment of dry eye in Sjogren syndrome. Eur J Ophthalmol. 2013;23:368–376.
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, Enriquez-de-Salamanca A, Calonge M, et al. Severity, therapeutic, and activity tear biomarkers in dry eye disease: an analysis from a phase III clinical trial. Ocul Surf. 2018;16:368–376.
   PubMed Web of Science ®Google Scholar
• Finis D, Hayajneh J, Konig C, et al. Evaluation of an automated thermodynamic treatment (LipiFlow®) system for meibomian gland dysfunction: a prospective, randomized, observer-masked trial. Ocul Surf. 2014;12:146–154.
   PubMed Web of Science ®Google Scholar
• Thode AR, Latkany RA. Current and emerging therapeutic strategies for the treatment of meibomian gland dysfunction (MGD). Drugs. 2015;75:1177–1185.
   PubMed Web of Science ®Google Scholar
• Albietz JM, Schmid KL. Intense pulsed light treatment and meibomian gland expression for moderate to advanced meibomian gland dysfunction. Clin Exp Optom. 2018;101:23–33.
   PubMed Web of Science ®Google Scholar
• Tsubota K, Yokoi N, Shimazaki J, et al. New perspectives on dry eye definition and diagnosis: a consensus report by the Asia Dry Eye Society. Ocul Surf. 2017;15:65–76.
   PubMed Web of Science ®Google Scholar
• Yokoi N, Uchino M, Uchino Y, et al. Importance of tear film instability in dry eye disease in office workers using visual display terminals: the Osaka study. Am J Ophthalmol. 2015;159:748–754.
   PubMed Web of Science ®Google Scholar
• Cho P, Yap M. Schirmer test. I. A review. Optom Vis Sci. 1993;70:152–156.
   PubMed Web of Science ®Google Scholar
• Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–574.
   PubMed Web of Science ®Google Scholar
• Jones L, Downie LE, Korb D, et al. TFOS DEWS II management and therapy report. Ocul Surf. 2017;15:575–628.
   PubMed Web of Science ®Google Scholar
• Hong S, Kim T, Chung SH, et al. Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjogren's syndrome. J Ocul Pharmacol Ther. 2007;23:78–82.
   PubMed Web of Science ®Google Scholar
• Nattinen J, Jylha A, Aapola U, et al. Topical fluorometholone treatment and desiccating stress change inflammatory protein expression in tears. Ocul Surf. 2018;16:84–92.
   PubMed Web of Science ®Google Scholar
• Pinto-Fraga J, Lopez-Miguel A, Gonzalez GM, et al. Topical fluorometholone protects the ocular surface of dry eye patients from desiccating stress: a randomized controlled clinical trial. Ophthalmology. 2016;123:141–153.
   PubMed Web of Science ®Google Scholar
• Amano S, Inoue K. Effect of topical 3% diquafosol sodium on eyes with dry eye disease and meibomian gland dysfunction. Clin Ophthalmol. 2017;11:1677–1682.
   PubMed Web of Science ®Google Scholar
• Lim SA, Nam S, Kwok SK, et al. Serologic markers are associated with ocular staining score in primary Sjogren syndrome. Cornea. 2015;34:1466–1470.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang X, Zheng Q, et al. Comparative evaluation of silicone hydrogel contact lenses and autologous serum for management of Sjogren syndrome-associated dry eye. Cornea. 2015;34:1072–1078.
   PubMed Web of Science ®Google Scholar
• Zang S, Cui Y, Cui Y, et al. Meibomian gland dropout in Sjogren's syndrome and non-Sjogren's dry eye patients. Eye. 2018;32:1681–1687.
   PubMed Web of Science ®Google Scholar
• Kang YS, Lee HS, Li Y, et al. Manifestation of meibomian gland dysfunction in patients with Sjogren's syndrome, non-Sjogren's dry eye, and non-dry eye controls. Int Ophthalmol. 2018;38:1161–1167.
   PubMed Web of Science ®Google Scholar
• Menzies KL, Srinivasan S, Prokopich CL, et al. Infrared imaging of meibomian glands and evaluation of the lipid layer in Sjogren's syndrome patients and nondry eye controls. Investig Ophthalmol Vis Sci. 2015;56:836–841.
   PubMed Web of Science ®Google Scholar